LRG1 Protein, Human, Recombinant (His)

Catalog No. TMPY-03966 Copy Product Info

LRG1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 35.8 kDa and the accession number is AAH34389.1.

LRG1 Protein, Human, Recombinant (His)

Catalog No. TMPY-03966

Copy Product Info

LRG1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 35.8 kDa and the accession number is AAH34389.1.

Pack Size	Price	USA Stock	Global Stock
5 μg	$93	7-10 days	7-10 days
10 μg	$152	7-10 days	7-10 days
20 μg	$248	7-10 days	7-10 days
50 μg	$498	7-10 days	7-10 days
100 μg	$817	7-10 days	7-10 days
200 μg	$1,330	7-10 days	7-10 days
500 μg	$2,930	7-10 days	7-10 days

Add to Cart

Add to Quotation

For In stock only · Estimated delivery:USA Stock (1-2 days) Global Stock (5-7 days)

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Resource Download

User Guide of Recombinant Proteins

Product Information

Biological Activity	Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description	LRG1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 35.8 kDa and the accession number is AAH34389.1.
Species	Human
Expression System	HEK293 Cells
Tag	C-His
Accession Number	AAH34389.1
Synonyms	LRG,leucine-rich α-2-glycoprotein 1,leucine-rich alpha-2-glycoprotein 1,HMFT1766
Construction	A DNA sequence encoding the human LRG1 (AAH34389.1)(Met1-Gln347) was expressed with a C-terminal polyhistidine tag. Predicted N terminal: Val 36
Protein Purity	> 95 % as determined by SDS-PAGE
Molecular Weight	35.8 kDa (predicted); 44-48 kDa (reducing conditions)
Endotoxin	< 1.0 EU/μg of the protein as determined by the LAL method.
Formulation	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization.
Reconstitution	A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.
Stability & Storage	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
Shipping	In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
Research Background	LRG1 (Leucine-Rich Alpha-2-Glycoprotein 1) is a Protein Coding gene. LRG1 belongs to the leucine-rich repeat (LRR) family. Members of this family are involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation. It contains 4 LIM zinc-binding domains and 1 Rho-GAP domain. LRG1 is involved in promoting neovascularization (new blood vessel growth) by causing a switch in transforming growth factor-beta (TGFbeta) signaling in endothelial cells. LRG1 binds to the accessory receptor endoglin and promotes signaling via the ALK1-Smad1/5/8 pathway. It may be a potential therapeutic target for the treatment of diseases where there is aberrant neovascularization. Diseases associated with LRG1 include Appendicitis and Normal Pressure Hydrocephalus.